B-mogen Biotechnologies, Inc.

Minneapolis, MN 55413

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $449K
First Award Date 05/01/17
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
HOGDAL LEAH JUSTINE HOGDAL 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 08/01/17 - 01/31/18

Abstract This proposal leverages our novel, unprecedented, and unique method for editing the mitochondrial genome. B-MoGen has exclusive license to this technology. This proposal will finally provide the final piece to complete the human genome project from a functional perspective since it has been impossible to make targeted gene knockouts in ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 05/01/17 - 11/30/17

Abstract Non-viral gene delivery is used in most biomedical laboratories for basic research and for many commercial and medical applications. These include basic investigations into gene function, modification of cells for the production of recombinant proteins, and generation of genetically modified human cells for cancer therapy (e.g. chimeric...